4//SEC Filing
Saxton Mark 4
Accession 0001209191-09-032883
CIK 0001040666other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:47 PM ET
Size
32.7 KB
Accession
0001209191-09-032883
Insider Transaction Report
Form 4
Saxton Mark
VP, U.S. Sales
Transactions
- Disposition to Issuer
Restricted Stock Units
2009-06-17−550→ 0 total→ Common Stock (550 underlying) - Disposition to Issuer
Employee Stock Options (right to buy)
2009-06-17−10,000→ 0 totalExercise: $12.21Exp: 2017-05-18→ Common Stock (10,000 underlying) - Disposition to Issuer
Common Stock
2009-06-17$29.00/sh−5,000$145,000→ 0 total - Disposition from Tender
Common Stock
2009-06-17$29.00/sh−13,855$401,795→ 5,000 total - Disposition to Issuer
Restricted Stock Units
2009-06-17−2,000→ 0 total→ Common Stock (2,000 underlying) - Disposition to Issuer
Common Stock
2009-06-17$29.00/sh−6,000$174,000→ 5,000 total - Disposition to Issuer
Restricted Stock Units
2009-06-17−4,500→ 0 total→ Common Stock (4,500 underlying) - Disposition to Issuer
Restricted Stock Units
2009-06-17−3,750→ 0 total→ Common Stock (3,750 underlying) - Disposition to Issuer
Employee Stock Options (right to buy)
2009-06-17−1,500→ 0 totalExercise: $6.96Exp: 2016-11-01→ Common Stock (1,500 underlying) - Disposition to Issuer
Restricted Stock Units
2009-06-17−4,000→ 0 total→ Common Stock (4,000 underlying) - Disposition to Issuer
Employee Stock Options (right to buy)
2009-06-17−4,832→ 0 totalExercise: $11.18Exp: 2015-05-12→ Common Stock (4,832 underlying) - Award
Common Stock
2009-06-17+6,000→ 11,000 total
Footnotes (14)
- [F1]These shares were tendered to Covidien Delaware Corp. (the "Purchaser") pursuant to Purchaser's offer to purchase all of the outstanding shares of VNUS Medical Technologies, Inc. (the "Issuer") at a cash purchase price of $29.00 per share, without interest thereon, and less any applicable withholding taxes, subject to the terms described in the Offer to Purchase for Cash filed with the Securities and Exchange Commission on May 18, 2009 (the "Tender Offer") and the Agreement and Plan of Merger, dated as of May 7, 2009, by and among Covidien Group S.a.r.l., the Purchaser and the Issuer (the "Merger"). Such shares were purchased by the Purchaser pursuant to the Tender Offer on June 17, 2009.
- [F10]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from November 1, 2006.
- [F11]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from November 1, 2005.
- [F12]These options, which were scheduled to vest in 48 successive and equal monthly installments measured from April 2, 2007, were canceled at the effective time of the Merger in exchange for a cash payment of $167,900.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F13]These options, which were scheduled to vest in 48 successive and equal monthly installments measured from November 1, 2006, were canceled at the effective time of the Merger in exchange for a cash payment of $33,060.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F14]These options, which were fully vested at the effective time of the Merger, were canceled at the effective time of the Merger in exchange for a cash payment of $86,106.24, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F2]Represents restricted stock units that were awarded to the Reporting Person on February 13, 2009, with the vesting of such restricted stock units subject to the achievement during 2009 of certain performance objectives, as determined by the Compensation Committee of the Board of Directors of the Issuer. Accordingly, the grant of these restricted stock units was not reported on Form 4. At the effective time of the Merger, these restricted stock units vested in full and were canceled in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
- [F3]Represents restricted stock units that vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
- [F4]Prior to the effective time of the Merger, the Reporting Person was entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
- [F5]These restricted stock units vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
- [F6]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from January 1, 2008.
- [F7]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from March 3, 2008.
- [F8]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from April 2, 2007.
- [F9]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from January 1, 2007.
Documents
Issuer
VNUS MEDICAL TECHNOLOGIES INC
CIK 0001040666
Entity typeother
Related Parties
1- filerCIK 0001396243
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:47 PM ET
- Size
- 32.7 KB